These models allow researchers to explore how localized biological systems interact with broader regulatory pathways
Metabolic benefits: Gains in lipid profile, blood pressure, and cardiovascular risk markers [1] [5]
Association of smoking with liver fibrosis and mortality in primary biliary cholangitis
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier